` Comparison: CIR vs CANF - Alpha Spread

CIR
vs
C
CANF

Over the past 12 months, CIR has underperformed CANF, delivering a return of 0% compared to the CANF's 88% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
CIR
CANF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

CIR Intrinsic Value
HIDDEN
Show
CANF Intrinsic Value
HIDDEN
Show
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Circassia Group PLC
LSE:CIR
36.5 GBX
C
Can Fite Biopharma Ltd
TASE:CANF
708 ILS
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
CIR, CANF

CIR
CANF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Circassia Group PLC
Revenue
C
Can Fite Biopharma Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
CIR, CANF

CIR
CANF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Circassia Group PLC
LSE:CIR
C
Can Fite Biopharma Ltd
TASE:CANF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

CIR
70.9%
CANF
0%

Operating Margin

CIR
5.8%
CANF
-1 487.2%

Net Margin

CIR
51.4%
CANF
-1 456.2%

FCF Margin

CIR
21.1%
CANF
-953.8%

ROE

CIR
20.8%
CANF
-382.9%

ROA

CIR
17.4%
CANF
-187%

ROIC

CIR
3.2%
CANF
-6 189.1%

ROCE

CIR
2.2%
CANF
-273.3%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
CIR, CANF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
CIR, CANF

Performance Gap Between CIR and CANF
HIDDEN
Show

Performance By Year
CIR, CANF

Loading
CIR
CANF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare CIR to other stocks
PNEXF
Pharnext SCA
More expensive
vs CIR
ABBV
Abbvie Inc
Cheaper
vs CIR
ATXS
Astria Therapeutics Inc
Cheaper
vs CIR
AMGN
Amgen Inc
Cheaper
vs CIR
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett